✦ LIBER ✦

Towards the most intensive group CHOP regimen for high-grade non-Hodgkin's lymphomas (NHL)

✍ Scribed by Santoro, A.; Latteri, F.; Balzarotti, M.; Parra, H.Soto; Salvini, P.; Brambilla, G.; Ginanni, V.; Biancofiore, G.; Bufalino, R.

Book ID: 122584114
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 155 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81751-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CHOP-VP16 chemotherapy and involved fiel

CHOP-VP16 chemotherapy and involved field irradiation for high grade non-Hodgkin's lymphomas: a phase II multicentre study

✍ Köppler, H; Pflüger, KH; Eschenbach, I; Pfab, R; Lennert, K; Wellens, W; Schmidt 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 723 KB

Consolidation radiotherapy to bulky dise

Consolidation radiotherapy to bulky disease in aggressive non Hodgkin's lymphoma. Results of the NHL B-94 trial of the German high grade NHL study group (DSHNHL)

✍ T.P. Nguyen; M. Kloess; M. Loeffler; L. Truemper; M. Pfreundschuh; C. Ruebe 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Alternating chemotherapy regimen (P-VABE

Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly

✍ Dr. F. Caracciolo; M. Petrini; E. Capochiani; F. Papineschi; G. Carulli; B. Gras 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB 👁 1 views

An intensive third generation regimen (P-VABEC) including adriamycin, etoposide, cyclophosphamide. vincristine, bleomycin and prednisolone was administered to 43 unselected elderly patients with intermediate or high-grade non-Hodgkin's lymphomas (NHL). The median age was 67, 40 per cent were Ann Arb

Combined surgery and chemotherapy for th

Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas

✍ Bosi, A; Bernardi, F; di Lollo, S; Ferrini, P Rossi; Bellesi, G; Alterini, R; Me 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 971 KB

The Impact of Age on Delivered Dose Inte

The Impact of Age on Delivered Dose Intensity and Hospitalizations for Febrile Neutropenia in Patients with Intermediate-Grade Non-Hodgkin's Lymphoma Receiving Initial CHOP Chemotherapy: A Risk Factor Analysis

✍ Morrison, Vicki A.; Picozzi, Vincent; Scott, Shane; Pohlman, Brad; Dickman, Elli 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 160 KB

A phase I trial to assess the value of r

A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (r-MetHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL)

✍ G. M. Smith; J. A. Child; M. H. Cullen; N. P. Bailey; C. M. Woodruffe; J. Fletch 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

In a multi-centre phase I study we investigated the possibility of reducing the interval between courses of standard CHOP (cyclophosphamide 750 mg/m2, doxorubicin 50 mg/m', vincristine 2 mgs day 1, and prednisolone 40mglm' days 1-8) from 21 days to 15 days and then 10 days using granulocyte colony s